and (b) an injection of unlabelled IMP, in a dose larger than that used for blood flow determination, does not dis place any labelled IMP previously taken up by the brain, nor does it displace any labelled IMP previously accumu lated in the lung that would lead to secondary brain up take. On the basis of these results, we conclude that se quential autoradiographic determinations of LCBF using IMP labelled with different radionuclides is possible. This is a promising experimental method for the simultaneous investigation of changes in LCBF in several CNS struc tures. Key Words: Cerebral blood flow-Double-radio nuclide autoradiography -Iodoamphetamine-Pharma cokinetics of amphetamines.
(LCBF) measurements as it is with radiolabelled microspheres (Heymann et aI., 1977) .
New radiopharmaceuticals have been synthe sized and recommended as tracers for imaging of cerebral perfusion in humans (Winchell et aI., 1980a,b) . One such agent is N-isopropyl-p-iodoam phetamine (IMP), which is also of proven value in experimental autoradiographic determinations of LCBF (Kuhl et aI., 1982; Lear et aI., 1982; Rapin et aI., 1984) . IMP has been shown to act in the brain as a "chemical microsphere": (a) It has a first-pass extraction coefficient of almost 1 00% (Winchell et aI., 1980b; Kuhl et aI., 1982; Pardridge and Fierer, 1985) ; (b) Kuhl et al. (1982) found that there is no significant release from the brain nor redistribution within brain tissue for at least 5 min following intra carotid injection; (c) results from several groups further suggest that IMP distribution represents CBF pattern during the first 30 min after tracer in jection (Kuhl et aI., 1982; Rapin et aI., 1983a-c) in the cortex, thalamus, and brainstem although not in the cerebellum (Jones et aI., 1986) . Considering these properties, sequential quantitative autoradio-graphic LCBF determinations should be possible, at least in some major brain structures, using suc cessive intravascular injections of IMP labelled with different radionuclides. Tissue concentrations of the various radionuclides could be differentiated in brain sections using multiple radionuclide autora diography (Lear et aI., 1981 (Lear et aI., , 1984 . The present work was undertaken to assess the feasibility of such sequential quantitative LCBF determinations in experimental animals.
In this series of experiments, sequential intravas cular bolus injections of [l25I]IMP and [I3lI]IMP were used. The results indicate that, provided the tracers are injected directly into the left ventricle, sequential autoradiographic determinations of LCBF using IMP labelled with different radionu clides is possible. This experimental method holds promise for the simultaneous investigation, at mul tiple CNS sites, of LCBF changes induced by drugs or by alterations in physiological state.
METHODS

Iodination of IMP
Te n milligrams of IMP (kit IK3; CEA-Oris, Gif-sur Yvette, France) was labelled with 1311 or 1 2 51 by an ex change reaction with J3JI-Na (3.7 GBq/ml; Amersham Int. pic, Amersham, England) or J 2 5I-Na (1 GB/ml; Amer sham), respectively, according to the procedure recom mended by CEA-Oris. This technique led to a radio chemical purity of <80%, and therefore a purification procedure similar to that described by Kuhl et a1. (1982) was carried out. The final radiochemical yield was 90%, and radio labelled IMP (['llIMP ) had a specific activity of �5 MBq/mg. All batches had their radiochemical purity checked following the purification procedure. Paper chromatography, using Whatman filter paper no. I and 100% butanone (methyl ethyl ketone) as solvent system, showed a purity of >92%. With this system, the Rr values for ['I]IMP and 'I were I and 0, respectively. ['I]IMP was dissolved in 2.5 ml of sterile normal saline before injec tion.
Animal preparation
Acute experiments were carried out in five adult cats (two female and three male; mean body weight 3.4 kg, range 3-4 kg). Animals were premedicated with xylazine hydrochloride (Rompun, 3 mg/kg i.m.; Bayer) and an aesthetized by inhalation of 4% halothane in oxygen de livered through a mask. The animals were intubated, with anaesthesia maintained with ex-chloralose (60 mg/kg i.v.), and paralysed. They were then ventilated with 30% ox ygen in nitrous oxide. Arterial Pco 2 , and Po 2 , and pH were monitored intermittently and ventilation adjusted to maintain normocapnia (Paco 2 close to 30 mm Hg). Body temperature was kept constant at 3rC using a feedback controlled heating pad.
Both femoral arteries were cannulated. One catheter was used to monitor blood pressure continuously and to collect samples for blood gases and pH determination. The other was used to divert blood into an extracorporeal circuit through which blood was circulated at a constant rate of 3.9 mllmin by means of a peristaltic pump. The circuit incorporated a coil, of 0.18-ml volume, placed in a well crystal gamma counter that was used to monitor continuously the radioactivity in the arterial blood. One femoral vein was cannulated distally for injecting drugs. The radioactive tracer solution was introduced through this cannula in two of the five animals. A catheter was also inserted proximally in this femoral vein for returning the arterial blood to the animal from the extracorporeal circuit. Before starting extracorporeal circulation, each cat received an intravenous injection of heparin (200 IU/kg; Edwin Burgess Ltd., England) .
In three animals the left ventricle of the heart was can nulated with a curved tip catheter, inserted proximally in the femoral artery and advanced to the heart. This cath eter was used for direct injection of ['I]IMP into the left ventricle.
In one animal the right middle cerebral artery (MCA) was exposed transorbitally (O'Brien and Waltz, 1973) and prepared for occlusion.
Experimental procedures
Our study was restricted to five experiments; these were designed to select a suitable route for the adminis tration of ['IlIMP when performing sequential LCBF measurements and to test the possibility of a displace ment of any [*IlIMP previously administered by a subse quent IMP injection.
Cat no. 1 received an intravenous bolus of [l31I]IMP (8.3 MBq/kg). During the ensuing 30 min, arterial blood, brain, and lung radioactivities were monitored. This was undertaken to test the possibility of injecting the tracer intravenously for autoradiographic studies of LCBF using labelled IMP.
Cat no. 2 was injected directly into the left ventricle with [1311]IMP (20 MBq/kg). Arterial blood and brain ra dioactivities were monitored and arterial blood samples were collected to determine the proportion of unmetabo lized IMP. At the end of the procedure, the brain was frozen in situ for autoradiographic analysis. This experi ment was undertaken to compare the brain uptake and washout of [J3JI]IMP with that obtained when the isotope was injected intravenously and to establish the param eters of the auto radiographic technique.
In cat no. 3, the dissected MCA was occluded for 18 min with a miniature Scoville clip. Te n minutes into the ischaemic period, the animal received the first intracar diac bolus of tracer ([1 2 5I]IMP, 8.3 MBq/kg). Twenty-two minutes after this injection and therefore 4 min into the reperfusion period, a bolus of the second tracer was given ([J3JI]IMP, 31.8 MBq/kg). Brain, lung, and arterial blood radioactivities were monitored. At the end of the experi ment, the brain was frozen in situ for double-radionuclide autoradiography.
It was thought possible that, in a double-tracer experi ment, the introduction of the second bolus of labelled IMP might displace part of the first-bolus IMP from its sites of uptake. Experiment nos. 4 and 5 were performed to test this possibility. In experiment no. 4, the animal received two doses of 10 mg of unlabelled IMP dissolved in saline, injected 5 (intravenously) and 10 (into the left ventricle) min after an injection of [l31I]IMP (3.9 MBq/kg) into the left ventricle. In experiment no. 5, 10 min after an intravenous injection of [l31I]lMP 0.2 MBq/kg), 10 mg of unlabelled IMP was injected intravenously. Brain, lung, and arterial blood radioactivities were monitored for the duration of these experiments.
Fractional part of arterial whole-blood radioactivity representing unmetabolized IMP
With animal no. 2, in which the radioactive tracer was injected into the left ventricle, 0.2-0.5-ml blood samples were collected from a three-way tap, placed in the extra corporeal circuit immediately downstream of the coil, to determine that fraction of arterial whole-blood activity associated with unmetabolized IMP. Blood was sampled each 15 s during the first 2 min after injection of ['3II]IMP, then at 2-min intervals during the next 10 min, and finally at 5-min intervals until the end of the experiment. Blood samples were extracted with octanol immediately after collection. Duplicate octanol extractions were performed on O.I-ml samples of whole blood, using 0.9 ml of oc tanol. The solvent and blood phases were counted with a gamma counter and compared. Kuhl et al. (1982) showed that the octanol-extracted activity represented only un metabolized IMP.
Blood, brain, and lung kinetics of labelled IMP Three sodium iodide scintillation detectors were used to assay in vivo radioactivity as follows. Arterial blood activity was assayed as the blood passed through a coil positioned within a shielded well crystal counter. Ex ternal counting over lung and brain was carried out using collimated crystals, each 25 mm in diameter by 25 mm thick. For brain measurements a cylindrical collimator 25
x 50 mm long was used; the end of the collimator was set up to be almost in contact with the brain surface. Lung measurements were made using a diverging collimator that gave a field of view 65 mm in diameter 50 mm from the end of the collimator.
Two methods were used simultaneously to record counts from the detectors. In the first system, the counts from each detector were accumulated in 1,024 channels of a multichannel analyser (series 35; Canberra, Meriden, CT, U.S.A.) operated in multiscaler mode. In the alter native system, ratemeter signals were digitized and stored on-line in a laboratory microcomputer (cube 10 system; Paul Fray Ltd., Cambridge).
Autoradiographic studies
Autoradiographic studies were undertaken with cat nos. 2 and 3. In these experiments, arterial blood passing through the extracorporeal coil at a constant rate was not returned to the animal for the first 2 min after the [*I]IMP injection, but was collected as a reference sample for LCBF determinations (Heymann et aI., 1977) . At the end of the experiment, the brains were frozen in situ by pouring liquid nitrogen into a funnel fixed to the exposed skull (P onten et aI., 1973) . Animals were decapitated when the freezing front reached the neck (�15 min), and the head was immersed in liquid nitrogen for later brain removal in a cold cabinet at -15°C. Twenty-micron-thick coronal sections were then cut in a -20°C cryostat (SLEE cryomicrotome; London), collected on glass slides, and instantly dried on a hot plate at 60°C. Single coated films (Kodak "X-Omat" GRS) were incubated in good contact with the tissue sections in x-ray cassettes. With cat no. 2, which received 20 MBq/kg [I3II]IMP, film and tissue sections were maintained in contact for 9 days. In cat no. 3, which received both [1 2 5I]IMP (8.3 MBq/kg) and [I3II]IMP (31.8 MBq/kg), a 5-day contact exposure was followed, 8 weeks later, by a 6-week exposure. With this latter experiment, the blackening of the autoradio graphic images obtained with the first exposure was 1987 mainly (�75%) due to the interaction of J311 emISSIOns with the sensitive emulsion; the second exposure re corded only the [' 2 5I]IMP distribution, because of I3II decay (8 weeks = 7 x I3II half-life).
After the brain of animal no. 3 was sectioned, six small samples of brain tissue (mean weight 125 mg) were col lected, weighed, and counted for their 1 2 51 and I3I1 radio activity with a gamma counter. One hundred-microliter aliquots of the reference blood sample(s), which had been collected at a constant flow rate, were included in the series of tubes to be counted. From these data, LCBF was computed using the classic equation developed for blood flow determinations with radioactive microspheres (Heymann et aI., 1977) : LCBF = F· BrlTr, where LCBF is expressed in ml/lOO g/min, F is the calibration flow rate (mUmin), Br is the radioactivity of the corresponding brain tissue sample (cpm/lOO g), and Tr is the total radio activity (cpm) sampled in the first 2 min after the injec tion of radiolabelled tracer.
RESULTS
Radiokinetics of [l31I]IMP in brain, lung, and arterial blood following intravenous bolus injection of tracer
When injected intravenously, a substantial pro portion of [13 1J]IMP was removed from the pulmo nary circulation by the lung and then slowly re leased into the arterial circulation ( Fig. 1) . As a re-
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FIG. 1. Arterial blood radioactivity following a bolus injec tion of [131IjN-isopropyl-p-iodoamphetamine in the left ven tricle (left curve; experiment no. 2; 20 MBq/kg) or intrave nously via the femoral vein (right curve; experiment no. 1; 8.3 MBq/kg). Radioactivity is expressed as a percentage of the peak radioactivity.
sult of this slow release of [13II]IMP, after a rapid initial increase, brain 13 11 radioactivity continued to rise steadily during the whole monitoring period. At the end of the monitoring period, brain 13 11 radioac tivity was 1.4 times that measured 5 min after the tracer injection. Experiment no. 5 confirmed the reversibility of the pulmonary accumulation of IMP. A lO-mg dose of unlabelled IMP, injected intravenously 10 min after an injection of [l3lI]IMP, produced a signifi cant decrement of lung radioactivity. This indicated a displacement of the labelled IMP that had been taken up by the lung (Fig. 2) . A concomitant in crease of brain radioactivity showed that part of the [131I]IMP displaced from the lung by unlabelled IMP was promptly taken up by the brain (Fig. 2) . Comparison of the pulmonary and cerebral radio kinetics of [l31I]IMP observed during experiment nos. 1 and 5 suggests that pulmonary uptake and/or binding of IMP can be very variable from one an imal to another and that this variability is reflected at the cerebral level.
Radiokinetics of [l3lI]IMP in brain and arterial blood following bolus injection of tracer directly into the left atrium
Injection of [13II]IMP directly into the left atrium avoids any contact of the tracer with the pulmonary vascular bed before its distribution through the ce rebral and peripheral circulation. Under such con ditions, immediately after injection of the radioiso tope, the cerebral uptake of [13II] lMP increased sharpy up to a plateau ( Fig. 3) . Radioactivity within the brain was recorded by means of a detector po sitioned along a vertical axis over the top of the ex posed skull. The transient peak of radioactivity that preceded the steady state probably reflected the ar rival of the radioactive bolus in the cerebral arteries within the field of view before its dispersal through 1200 cps 1 i. v. bo Ius injection ot 10 �g co Id IMP brain Lung the capillaries. Thereafter, brain radioactivity de creased at a very slow rate under normal physio logic conditions; the cerebral clearance rate for [l3lI]IMP was 0.25 and 0.3%/min in cat nos. 2 and 4, respectively. Cat no. 4 received labelled IMP ([ 131I]IMP) into the left ventricle and showed a 12.3% decrease of lung radioactivity immediately after the intrave nous injection of unlabelled IMP, which confirmed the data obtained from experiment nos. 1 and 2 re lating to the reversibility of IMP uptake by the lung. This release of IMP by the lungs produced a signifi cant increase in brain radioactivity (Table 1) . No significant change in the pulmonary radio kinetics could be detected following the intracardiac injec tion of unlabelled IMP (Tab]e I), although some re lease must have taken place since a very small in crease (0.7%) of brain radioactivity was still detect able owing to the powerful sensitivity of our detection system. When [13II]IMP was injected into the left ven- [l31I]IMP was injected first into the left ventricle (i. c.); intrave nous and intracardiac unlabelled IMP was injected after the ra dioisotope injection at 5 and 10 min, respectively. Values are means ± SD. a p < 0.001.
b P < 0.05.
Mean ± SD; *P < 0.05; **P < 0.001 (Student's t test).
tricle, the peak of arterial blood radioactivity was much sharper than with intravenous injection (Fig.  1) . In cat no. 2, which received [*I]IMP into the left ventricle, blood radioactivity fell to 1.8% of its peak value in 45 s. During the period corresponding to the first pass of [*I]IMP in the circulation, the pro portion of arterial whole-blood radioactivity repre senting unmetabolized IMP was measured to be 95% (Kuhl et al. 's method) ; this corresponded roughly to the radiochemical purity of the prepara tion. Thereafter, the unmetabolized fraction rapidly decreased to remain steady at 80%.
Autoradiographic study of LCBF during and following experimentally induced ischaemic period In experiment no. 4, separate intracardiac injec tions of [125I]IMP and [13 1I ]IMP were administered: one during transient focal cerebral ischaemia, the other 4 min after reperfusion. The cerebral radio kinetics monitored under these circumstances were very similar to those recorded under normal physi ological conditions (Fig. 4) , except that the clear ances of [*I]IMP from brain tissue, especially during ischaemia, were higher than in the control experiments (Fig. 5 ). Typical autoradiographs ob tained with two different exposures of a single co ronal brain section are displayed in Fig. 6 . The LCBF values determined by assaying the radioac tivity in small tissue samples collected after brain sectioning confirmed that LCBF was reduced by MCA occlusion in the ipsilateral hemisphere. They also showed that in two of the three regions sam pled in the superior cerebral cortex of the is chaemic hemisphere, immediately after reperfu sion, LCBF appeared slightly increased relative to that of the symmetrical structures in the opposite control hemisphere. 
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DISCUSSION
A limitation of single-nuclide autoradiography for studying LCBF changes under a wide variety of physiological and experimental conditions lies in the intrinsic variability of LCBF, unrelated to the experimental manipulation. Thus, detection of small but significant alterations in LCBF requires the use of large groups of animals. A solution to this problem is to use each subject as its own con trol, by employing two radiolabelled forms of a CBF tracer acting as a "chemical microsphere, " administered sequentially during the control and the subsequent experimental state. A sequential, double-label autoradiographic method, based on the same principle, has already been developed to quantify altered rates of regional glucose metabo lism (Olds et aI., 1985) .
Single autoradiographic determinations of LCBF using radiolabelled IMP have been validated under normal physiological conditions, and a good corre spondence over a wide range of flows was found between LCBFs based on IMP and those deter mined with radiolabelled microspheres . Double-radionuclide autoradiography was also used to compare the simultaneous uptake of [123I]IMP and [14C] iodoantipyrine; studies with awake and anaesthetized rats showed that autora diographic measurements of LCBF obtained with IMP agreed closely with those using iodoantipyrine within the flow range 20-300 mll lOO g/min (Lear et aI., 1982) . These authors also showed that a linear uptake tracer model could be used for IMP, yielding more precise values for LCBF values above 150 mlllOO g/min.
The problem of changes in regional distribution of IMP with time was also examined (Kuhl et aI., 1982; Rapin et a!., 1983a-c) . Results obtained by only the medial marginal gyrus and the structures located centrally were spared. B: Film blackening in this autoradiograph was due mainly to the interaction of 1311 emissions with the sensitive emulsion, and therefore it gives information on LCBFs during the early phase of recirculation. Reactive hyperaemia occurred in the caudate nucleus (arrow) and in the subcortical white matter superolateral to the caudate nucleus (note the sharp boundary denoted by the arrow). This confirms previous data obtained with single autoradiographic determination of LCBF with inert diffusible tracers (Ginsberg et aI., 1978; Kagstrom et aI., 1983) , and with repeated LCBF measurements using the hydrogen clearance technique (Miller et aI., 1980; Tamura et aI., 1980) . One focus of impaired perfusion was also present in the upper cerebral cortex (0, lateral marginal gyrus and medial suprasylvian gyrus), confirming previous reports that a persistent obstruction of microvessels can occur following focal cerebral ischaemia (Ames et aI., 1968; Olsson and Hossmann, 1971 ). More recent work suggests that this "no-flow" phenomenon may be transient and could be reversed by increasing the arterial blood pressure (Ito et aI., 1980) . Rapin et al. (1983b, c) indicate that the distribution of IMP 1 h after its administration is different from that observed at 3 min after injection, and that it is no longer an exact picture of LCBF. Overall, the data obtained with rats by Kuhl et al. (1982) and Rapin et al. (1983a-c) suggested that a I-h delay between IMP injection and animal death is the upper limit at which IMP distribution may still be considered as representing LCBFs. Clinical re search confirmed the redistribution of IMP with time among some brain structures. Creutzig et al. (1986) found that only IMP single-photon emission computed tomography images done not later than 30 min after tracer injection reflect CBF. Very re cently Jones et al. (1986) reported that 40 min after a bolus injection of 1231 amines (I MP and N,N,N' trimethyl-N' -[2-hydroxyl-3-methyl-5-iodobenzyl]-1,3-propanediamine (HIPDM), the distribution of the tracers was related to the CBF pattern in the cortex, thalamus, and brainstem but not in the cere bellum. On the basis of this information, it appears that [* I]IMP distribution reflects LCBFs in the cortex, thalamus, and brainstem, only if death occurs within 30 min after IMP injection.
Intravenous bolus injection of labelled IMP unsuitable for sequential determinations of LCBFs
In our experiments with cats, [*I]IMP injected in travenously was avidly sequestered by the lung and then steadily released into the arterial circulation. Similar lung radiokinetics were observed following an intravenous injection of this radioactive agent in monkeys (Winchell, 1980b) , dogs (Rahimian et aI., 1984) , rabbits (de Bruine et aI., 1985) , and humans (Holman et aI., 1983; Moretti et al., 1983; Ko bayashi et aI., 1985) . These reflect the ability of the pulmonary capillary bed to accumulate nonbiogenic basic amines without metabolic interaction. This function of the lung is favoured by the huge surface area of the pulmonary capillary bed and its receipt of the entire cardiac output [for a review see Bakhle and Vane (1977) ] .
To uya et al. (1985) showed that the mechanism by which IMP is extracted by the lung from arterial circulation involves a saturable binding system, presumably of receptors. The partial displacement of [13II]IMP from the lung by an intravenous injec tion of unlabelled IMP (Fig. 2) confirms the satura bility of its pulmonary binding. Previous work with dogs showed that these receptors are nonspecific; Rahimian et al. (1984) observed that ketamine de creases the uptake capacity of the lung endothelium for IMP, and Akber et al. (1985) found that pro pranolol decreases the lung uptake of IMP in a dose-related effect. Exposures in vivo to gaseous anaesthetics or to high concentrations of oxygen were also shown to change amine inactivation pro cesses in lung (Youdim et aI., 1980) . Therefore, it might be expected that even changes in the external environment of the lung may significantly alter its IMP binding.
As observed previously with monkeys (Winchell et al., 1980b) and humans Holman et aI., 1983; Moretti et al., 1983; Ko-bayashi et aI., 1985) , the slow release of IMP by the lung into the arterial circulation induced a steady increase of cerebral radioiodine. Similarly, a sudden decrease of lung radioactivity resulting from the displacement of [*I]IMP was promptly fol lowed by increased uptake in the brain (Fig. 2) . Therefore, a second intravenous injection of differ ently labelled IMP would displace part of the [*I]IMP previously captured by the lung; this dis placed [*I]IMP, once released into the arterial blood, would be taken up by the brain and would interfere with the previous brain distribution of the tracer. These results clearly show that intravenous administration of [*I]IMP for sequential determina tions of LCBF will add considerable complexity to the computation required to separate the two iso topes.
Radiokinetics of [*I]IMP following its injection in the left ventricle
The injection of [*I]IMP into the left ventricle avoids any preliminary contact of the tracer with the pulmonary vascular bed; the total amount of tracer is distributed first through the cerebral and peripheral circulation, where most of it can be taken up by the brain and other organs. Our data suggest that the remaining diluted tracer reaching the pulmonary circulation was entirely sequestered by the lung, without any significant further release, probably because the receptors were not saturated by the small amount of IMP that had reached the pulmonary endothelium. The very narrow peak of arterial blood radioactivity that was obtained when [*I]IMP was injected directly into the left ventricle also supported this hypothesis (Fig. 1) . However, part of the [*I]IMP bound to the lungs could still be displaced by a large amount of unlabelled IMP ad ministered intravenously, thus confirming the re versibility of the pulmonary binding (Table 1) . A large amount of unlabelled IMP injected in the left ventricle also induced a detectable increase of brain [*I]IMP, probably owing to some release of [*I]IMP by the lungs, but this change was very small (0.7% increase). Octanol fractionation of arterial blood samples showed that 80% of the residual circulating radioiodine remained bound to unmetabolized IMP and therefore could be taken up by the brain. How ever, the amount of residual circulating [*I]IMP seems too small to interfere significantly with the brain radiokinetics.
The sequence of events proposed above is con sistent with the very rapid rise of brain radioac tivity to a plateau (Fig. 3) . The change of brain ra dioactivity with time that we monitored in cats after an injection of [*I]IMP in the left ventricle was very J Cereb Blood Flow Metab, Vol. 7, No. 3, 1987 similar to that observed by Kuhl et aI. (1982) with monkeys after bolus injection of [1231]IMP into the carotid artery. However, in their experiments the washout of the radioactivity from the brain, with a half-time of 63 min, was relatively more rapid than that that we observed in cats under normal physio logical situations; the half-time in cat no. 1 was at least 167 min based upon an observation period of 17 min from the time of injection. This discrepancy may be due to species-related differences or to the use of different anaesthetics (ketamine and pento barbital in the experiments of Kuhl et aI.; halothane and ex-chloralose in ours). An injection of a lO-mg dose of unlabelled IMP did not displace any of the [*I]IMP previously taken up by the brain, which suggests that IMP has an affinity for high-capacity binding sites in brain tissue. It also indicates that a second injection of differently labelled IMP is un likely to interfere with the brain distribution of the [*I]IMP previously bound, provided the first radio active tracer bolus had been injected in the left ven tricle.
These results confirm previous reports that IMP has a first-pass extraction close to 100%, with a minimal brain-to-blood back diffusion (Winchell et aI., 1980b; Kuhl et aI., 1982; Pardridge and Fierer, 1985) , probably because of its affinity for high-ca pacity and relatively nonspecific binding sites (Winchell et aI., 1980a) . Therefore, IMP does be have as a "chemical microsphere," and it can be used for sequential autoradiographic determina tions of LCBF. However, one should bear in mind that changes in the regional distribution of IMP occur with time. On the basis of previous results reviewed above (Kuhl et aI., 1982; Rapin et aI., 1983a-c; Creutzig et aI., 1986; Jones et aI., 1986) , we consider that accurate LCBF determinations would be obtained in the cortex, thalamus, and brainstem, provided they were measured within 30 min of the time of tracer injection.
Double-autoradiographic determinations of LCBFs using [125I]IMP and [l3lI]IMP
In our study, we used double-radionuclide auto radiography with 13 11 and 1251 for the following reasons: commercial availability, simple iodination procedure, and high-resolution autoradiography. As shown in Fig. 6 , autoradiographic discrimina tion of these two radionuclides is readily achieved, at least partially, by taking advantage of their dif ferent half-lives (8.04 and 60.1 days for 1311 and 1251, respectively), using the technique of Lear et aI. (1981 Lear et aI. ( , 1984 . An even better discrimination would have been possible using 14C instead of 1251. Mod ern computer techniques exist for image analysis that are capable of generating fully discriminated digital images of sequential LCBF determinations; unfortunately, such equipment was not available to us. Once the two radionuclides are discriminated on separate autoradiographs, they can easily be quantified by plotting the optical density of various anatomical regions against their tissue radioac tivity. This can be achieved, as in this series of ex periments, by counting small tissue samples col lected from the frozen brain during sectioning, to gether with aliquots of the arterial blood samples collected at a constant reference flow rate. LCBFs can then be determined using the equation devel oped for LCBF determinations with radionuclide labelled particles (Heymann et aI., 1977) .
The autoradiographs shown in Fig. 6 illustrate the potential of sequential autoradiographic LCBF determinations. They allowed us to characterize the CBF changes of CNS structures during recircu lation after ischaemia and to relate them to the level of CBF during the ischaemic period.
Possible pitfalls in using radioactive IMP for LCBF measurements
The main advantages of "chemical micro spheres" such as IMP are their flow-limited brain clearance (first-pass extraction > 98%) and their tight binding to some brain tissue component, which minimizes back diffusion. With these fea tures in mind, it may be expected that any patho logical, experimental, or pharmacological event likely to impair either the transport of IMP across the blood-brain barrier and/or its brain sequestra tion is likely to interfere with IMP LCBF measure ments.
Decreased transport of IMP across blood-brain barrier. Generally, non-carrier-mediated passage of an amine across the blood-brain barrier is attrib uted to free diffusion of its nonionized lipophilic form (Oldendorf, 1974) . However, various data suggest that this is not the case for IMP, nor for other lipophilic basic drugs: (a) Studying several io dophenylalkyl amines including IMP, Winchell et ai. (1980a) found that neither concentration of the free amine at body pH nor lipophilicity correlated with their ability to be taken up by the brain, which suggests that a transport mechanism other than free diffusion is involved. (b) Earlier work from Par dridge and Connor (1973) showed that ampheta mines cross the blood-brain barrier mainly by non saturable free diffusion, but also by a nonstereo specific saturable mechanism. (c) Similarly to amphetamine, the blood-brain barrier transport of propranolol and lidocaine involves a saturable transport system, with a Km indicative of a very low affinity of the blood-brain barrier transport sites for the drug (Pardridge et aI., 1984) .
Several previous studies have shown that the ex traction of IMP approaches the flow-limited value under physiological conditions (Winchell et aI., 1980b; Kuhl et aI., 1982; Pardridge and Fierer, 1985) , but Kuhl et ai. (1982) found that brain ex traction of IMP was decreased from a value of 92 to 74% when the arterial blood pH was lowered from 7.35 to 7.10. Pardridge's group proposed that this may be a pH effect (Pardridge and Fierer, 1985) since amphetamine(s) as well as other lipophilic basic amines are transported through the blood brain barrier substantially more slowly at lower pH (Pardridge and Connor, 1973; Pardridge et al., 1984) . Therefore, it appears that LCBF measure ments with IMP as tracer should be further vali dated under conditions associating high CBF with low arterial blood pH, e.g., during respiratory aci dosis.
Altered brain sequestration of IMP. Drugs such as propanolol, lidocaine, and IMP are sequestered by the brain because of their binding to high-ca pacity saturable cytoplasmic systems that exist in brain for lipophilic amines (Winchell et aI., 1980a; Pard ridge et aI., 1984) . Thus, IMP should be used very cautiously for studying possible LCBF changes induced by lipophilic amines; by com peting with IMP at both the blood-brain barrier and binding sites, these drugs are likely to alter the regional distribution of the imaging agent indepen dently of changes due to alteration of CBF.
The binding of lipophilic amines in the brain was also shown to be reduced under certain physiolog ical and pathological conditions. Pardridge et ai. (1984) observed that the rate of brain sequestration of propranolol in the newborn rabbit was markedly lower in comparison with that of the adult rat, which indicates either a developmental or a species modulation in the sequestration of lipophilic amines by the brain. Our studies (Fig. 5 ) strongly suggest that ischaemia decreases the affinity of brain tissue for binding IMP, and this may also occur in me chanically generated cortical lesions (Lear et aI., 1982) . Clinical studies have demonstrated that ab normal brain cells (primary tumours) lose the ca pacity to extract IMP regardless of tumour type, perfusion rate, or blood-brain barrier dysfunction (Lafrance et aI., 1981; Hill et aI., 1982; Creutzig et aI., 1986) .
Therefore, before using IMP as a CBF tracer under any pathological or experimental situations, its binding to brain tissue should be tested under the same conditions. Such a preliminary validation of the method could be performed as described by Lear et al. (1982) , i.e., using direct autoradiogra phic comparison of the simultaneous uptake of [*I]IMP with that of [14C]iodoantipyrine taken as reference tracer. In some instances, as, for ex ample, with tumours, the capacity of brain tissue to bind [*I]IMP could be directly evaluated in vitro; localization of receptor binding sites in freeze-dried brain sections with quantitative autoradiography is now common practice (Whitehouse, 1985) .
Possible pharmacological ef fects of IMP. Am phetamine and some structural analogues are po tent sympathomimetics with well-known CNS stim ulant effects. Because of the close relationship be tween functional activity, metabolic rate, and CBF, an increase of CBF would be expected following administration of amphetamine(s). Indeed, signifi cant elevations of cerebral oxygen and glucose consumption together with an increase in cerebral tissue perfusion were observed 30 min after am phetamine administration in rats (5 mg/kg i. p.) (Carlsson et al., 1975; Berntman et aI. , 1976) and baboons (1.25 mg/kg i.v.) (McCulloch and Harper, 1977) . Furthermore, the results of Wechsler et al. (1979) suggest that amphetamine(s)-induced CBF changes could be inhomogeneous; using [14C] de oxyglucose they identified specific brain structures in which metabolic rate was altered after ampheta mine administration.
In our experiments, a slight and transient de crease of the arterial blood pressure was detectable immediately after the administration of 10 mg unla belled IMP given either intravenously or into the left ventricle. The LCBF autoradiographs that we obtained with brain tissue under normal physiolog ical conditions did not show any obvious inhomo geneity, as opposed to what could be expected from the results of Wechsler et al. (1979) . However, Hossmann et al. (1985) did observe EEG modifica tions in cats that received IMP doses of >0.9 mg/kg, suggesting that IMP could produce alter ations of neuronal excitability. In the light of these findings, [*I]IMP of a high specific activity should be used to minimize the possibility of pharmacolog ical effects; Hossmann et al. recommended IMP doses of <0.6 mg/kg.
Our study has shown that sequential autoradio graphic determination of LCBF with differently ra diolabelled IMP is possible and has demonstrated the utility of sequential arterial injections for [*I]IMP administration. Sequential autoradiogra phic determinations of LCBF appear to be a prom ising experimental method for the simultaneous in vestigation of LCBF changes in all brain structures. Other drugs have been shown to behave similarly as "chemical micro spheres ," and with IMP they J Cereb Blood Flow Metab. Vol. 7. No.3. 1987 could be used for multiple sequential autoradiogra phic determinations of LCBF (flunitrazepam Gjedde et aI., 1983; Silverstein et aI., 1984; dieth yldithiocarbamate-de Bruine et aI., 1985) . Finally, as a result of its relatively slow brain-to-blood back diffusion, it is not necessary to kill the animal im mediately after injecting [*I]IMP for LCBF determi nations. Therefore, the brain can be frozen in situ using the technique of Ponten et al. (1973) , which allows various imaging techniques of brain metabo lism to be used with IMP determinations of LCBF (Hossmann et aI., 1985) .
